Cargando…
A Difference in Bleeding and Use of Blood and Blood Products in Patients who Were Preoperatively on Aspirin or Dual Antiplatelet Therapy Before Coronary Artery Bypass Grafting
BACKGROUND: Postoperative bleeding in patients who underwent elective coronary artery bypass surgery (CABG) may increase due to preoperative anticoagulant therapy indicative of their disease - acute coronary syndrome or implanted coronary artery stent. Increased bleeding in many cases requires the u...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Medical Sciences of Bosnia and Herzegovina
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789565/ https://www.ncbi.nlm.nih.gov/pubmed/29416215 http://dx.doi.org/10.5455/medarh.2018.72.31-35 |
_version_ | 1783296304361766912 |
---|---|
author | Straus, Slavenka Haxhibeqiri-Karabdic, Ilirijana Grabovica, Sanja Granov Granov, Nermir |
author_facet | Straus, Slavenka Haxhibeqiri-Karabdic, Ilirijana Grabovica, Sanja Granov Granov, Nermir |
author_sort | Straus, Slavenka |
collection | PubMed |
description | BACKGROUND: Postoperative bleeding in patients who underwent elective coronary artery bypass surgery (CABG) may increase due to preoperative anticoagulant therapy indicative of their disease - acute coronary syndrome or implanted coronary artery stent. Increased bleeding in many cases requires the use of blood and blood derivatives, and sometimes even reoperation. Their use poses the risk of complications, may extend the hospitalization. METHODS: Our observation retrospective study included 131 patients, 41 treated with aspirin and 90 treated with aspirin and clopidogrel. All underwent for the first time elective on-pump isolated CABG surgery at Clinic for cardiovascular surgery of Clinical Center University of Sarajevo, in period June 2016 to September 2017. The data were collected from patient’s records. RESULTS: Out of 131 patients,73.3% were male. The average age was 62. The average total drainage during the first 48 postoperative hours in ASA group was 1027.4±404.9ml and 1049.8±371.3ml in DAPT group. The mean number of whole blood transfusions in the DAPT group washigher compared to ASAgroup. The average number of fresh frozen plasma were higher in the DAPT group 0.84±0.51 compared to the group ASA 0.39±0.07, as well the average thrombocytes transfusions were slightly higher in the DAPT group. Statistical analysis suggests that there is no significant difference between the observed groups (p>0.05). Also, our study did not show a statistically significant difference between arrhythmia onset, the length of mechanical ventilation, use of protamineand tranexamic acid. Reoperation due to postoperative bleeding was recorded in 2 cases in the DAPT group as well as 2 lethal cases. CONCLUSION: In our study, we could not demonstrate less postoperative bleeding and use of blood and blood products in a group of patients who were preoperatively treated with aspirin compared to patients with dual antiplatelet therapy in the elective isolated CABG surgery. |
format | Online Article Text |
id | pubmed-5789565 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Academy of Medical Sciences of Bosnia and Herzegovina |
record_format | MEDLINE/PubMed |
spelling | pubmed-57895652018-02-08 A Difference in Bleeding and Use of Blood and Blood Products in Patients who Were Preoperatively on Aspirin or Dual Antiplatelet Therapy Before Coronary Artery Bypass Grafting Straus, Slavenka Haxhibeqiri-Karabdic, Ilirijana Grabovica, Sanja Granov Granov, Nermir Med Arch Original Paper BACKGROUND: Postoperative bleeding in patients who underwent elective coronary artery bypass surgery (CABG) may increase due to preoperative anticoagulant therapy indicative of their disease - acute coronary syndrome or implanted coronary artery stent. Increased bleeding in many cases requires the use of blood and blood derivatives, and sometimes even reoperation. Their use poses the risk of complications, may extend the hospitalization. METHODS: Our observation retrospective study included 131 patients, 41 treated with aspirin and 90 treated with aspirin and clopidogrel. All underwent for the first time elective on-pump isolated CABG surgery at Clinic for cardiovascular surgery of Clinical Center University of Sarajevo, in period June 2016 to September 2017. The data were collected from patient’s records. RESULTS: Out of 131 patients,73.3% were male. The average age was 62. The average total drainage during the first 48 postoperative hours in ASA group was 1027.4±404.9ml and 1049.8±371.3ml in DAPT group. The mean number of whole blood transfusions in the DAPT group washigher compared to ASAgroup. The average number of fresh frozen plasma were higher in the DAPT group 0.84±0.51 compared to the group ASA 0.39±0.07, as well the average thrombocytes transfusions were slightly higher in the DAPT group. Statistical analysis suggests that there is no significant difference between the observed groups (p>0.05). Also, our study did not show a statistically significant difference between arrhythmia onset, the length of mechanical ventilation, use of protamineand tranexamic acid. Reoperation due to postoperative bleeding was recorded in 2 cases in the DAPT group as well as 2 lethal cases. CONCLUSION: In our study, we could not demonstrate less postoperative bleeding and use of blood and blood products in a group of patients who were preoperatively treated with aspirin compared to patients with dual antiplatelet therapy in the elective isolated CABG surgery. Academy of Medical Sciences of Bosnia and Herzegovina 2018-02 /pmc/articles/PMC5789565/ /pubmed/29416215 http://dx.doi.org/10.5455/medarh.2018.72.31-35 Text en © 2018 Slavenka Straus, Ilirijana Haxhibeqiri-Karabdic, Sanja Granov Grabovica, Nermir Granov http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Paper Straus, Slavenka Haxhibeqiri-Karabdic, Ilirijana Grabovica, Sanja Granov Granov, Nermir A Difference in Bleeding and Use of Blood and Blood Products in Patients who Were Preoperatively on Aspirin or Dual Antiplatelet Therapy Before Coronary Artery Bypass Grafting |
title | A Difference in Bleeding and Use of Blood and Blood Products in Patients who Were Preoperatively on Aspirin or Dual Antiplatelet Therapy Before Coronary Artery Bypass Grafting |
title_full | A Difference in Bleeding and Use of Blood and Blood Products in Patients who Were Preoperatively on Aspirin or Dual Antiplatelet Therapy Before Coronary Artery Bypass Grafting |
title_fullStr | A Difference in Bleeding and Use of Blood and Blood Products in Patients who Were Preoperatively on Aspirin or Dual Antiplatelet Therapy Before Coronary Artery Bypass Grafting |
title_full_unstemmed | A Difference in Bleeding and Use of Blood and Blood Products in Patients who Were Preoperatively on Aspirin or Dual Antiplatelet Therapy Before Coronary Artery Bypass Grafting |
title_short | A Difference in Bleeding and Use of Blood and Blood Products in Patients who Were Preoperatively on Aspirin or Dual Antiplatelet Therapy Before Coronary Artery Bypass Grafting |
title_sort | difference in bleeding and use of blood and blood products in patients who were preoperatively on aspirin or dual antiplatelet therapy before coronary artery bypass grafting |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789565/ https://www.ncbi.nlm.nih.gov/pubmed/29416215 http://dx.doi.org/10.5455/medarh.2018.72.31-35 |
work_keys_str_mv | AT strausslavenka adifferenceinbleedinganduseofbloodandbloodproductsinpatientswhowerepreoperativelyonaspirinordualantiplatelettherapybeforecoronaryarterybypassgrafting AT haxhibeqirikarabdicilirijana adifferenceinbleedinganduseofbloodandbloodproductsinpatientswhowerepreoperativelyonaspirinordualantiplatelettherapybeforecoronaryarterybypassgrafting AT grabovicasanjagranov adifferenceinbleedinganduseofbloodandbloodproductsinpatientswhowerepreoperativelyonaspirinordualantiplatelettherapybeforecoronaryarterybypassgrafting AT granovnermir adifferenceinbleedinganduseofbloodandbloodproductsinpatientswhowerepreoperativelyonaspirinordualantiplatelettherapybeforecoronaryarterybypassgrafting AT strausslavenka differenceinbleedinganduseofbloodandbloodproductsinpatientswhowerepreoperativelyonaspirinordualantiplatelettherapybeforecoronaryarterybypassgrafting AT haxhibeqirikarabdicilirijana differenceinbleedinganduseofbloodandbloodproductsinpatientswhowerepreoperativelyonaspirinordualantiplatelettherapybeforecoronaryarterybypassgrafting AT grabovicasanjagranov differenceinbleedinganduseofbloodandbloodproductsinpatientswhowerepreoperativelyonaspirinordualantiplatelettherapybeforecoronaryarterybypassgrafting AT granovnermir differenceinbleedinganduseofbloodandbloodproductsinpatientswhowerepreoperativelyonaspirinordualantiplatelettherapybeforecoronaryarterybypassgrafting |